About Us: Investors

The Heart Failure Program is supported, by way of three-year unrestricted grants provided directly to CCS. The Heart Failure Program is pleased to acknowledge the continued support of AstraZeneca.

Investor support enables the Heart Failure Program tocontinue to provide:

	Quality national symposia and workshops to over 3000 participants per year
	Create valuable tools and resources such as the website, online learning modules, office and ward algorithms pocket card and slide sets that meet the needs of the end users
	Produce annual guidelines that include recommendations and practical tips, which are published yearly in Pulses -The Canadian Journal of Cardiology.
	Most importantly contributions help the Heart Failure Program improve practice through partnerships and knowledge translation

The CCS continues to seek unrestricted investor support for the Heart Failure Program.

For information on the levels of investment or to become an investor, please contact Carolyn Pullen, Director, Knowledge Translation (pullen@ccs.ca).